Abnormal activation of NF-κB has been implicated in AD (Kaltschmidt et al., 1997), and Lian et al. (2015) showed that exposure to Aβ activates astroglial NF-κB and C3 release. This evidence concerns the gene NFKB1 and Alzheimer disease.